Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Posts Q3 Revenue Increase Amid Shrinking Losses and R&D Spending Dip

NEW YORK, Oct. 28 (GenomeWeb News) - Sequenom today reported an increase in revenues for the three months ended Sept. 30, 2003, accompanied by narrowed losses and a drop in R&D spending.

The company's total revenues for the quarter were $7.2 million, compared to $6.9 million for the third quarter of 2002. Product revenues for the company's Genetic Systems business unit were flat at $6.5 million for the quarter, compared to $6.5 million for the year ago period. Revenues for Sequenom's Pharmaceuticals business unit were approximately $600,000 for the quarter, compared to $400,000 for the third quarter of 2002. Sequenom said its Pharmaceuticals revenues were primarily from genetic services.

Sequenom's net loss for the quarter decreased to $8.8 million, compared to $17.0 million for the third quarter of 2002.

Research and development expenses dropped 34 percent year-over-year, to $6.0 million in the third quarter of 2003 compared to $9.2 million in the year-ago period.

As of Sept. 30, Sequenom held cash, cash equivalents, short-term investments, and restricted cash totaling $73.2 million.

"We remain on track to achieve our estimated year-end cash balance of $65 million, which we believe should adequately address our cash needs through 2005," said Steve Zaniboni, Sequenom's CFO in a statement.

The Scan

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.

EHR Quality Improvement Study Detects Demographic-Related Deficiencies in Cancer Family History Data

In a retrospective analysis in JAMA Network Open, researchers find that sex, ethnicity, language, and other features coincide with the quality of cancer family history information in a patient's record.

Inflammatory Bowel Disease Linked to Gut Microbiome Community Structure Gradient in Meta-Analysis

Bringing together data from prior studies, researchers in Genome Biology track down microbial taxa and a population structure gradient with ties to ulcerative colitis or Crohn's disease.

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.